Injectable Hydrogel Loaded with CDs and FTY720 Combined with Neural Stem Cells for the Treatment of Spinal Cord Injury
DOI: https://doi.org/10.2147/ijn.s448962
IF: 7.033
2024-05-08
International Journal of Nanomedicine
Abstract:Zhiping Qi, 1 Su Pan, 1 Xiaoyu Yang, 1 Renfeng Zhang, 1 Cheng Qin, 1 Hongye Yan, 1 Longchuan Zhu, 1 Weijian Kong 2 1 Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China; 2 Department of Nuclear Medicine, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China Correspondence: Weijian Kong; Longchuan Zhu, Email ; Purpose: Spinal cord injury (SCI) is an incurable and disabling event that is accompanied by complex inflammation-related pathological processes, such as the production of excessive reactive oxygen species (ROS) by infiltrating inflammatory immune cells and their release into the extracellular microenvironment, resulting in extensive apoptosis of endogenous neural stem cells. In this study, we noticed the neuroregeneration-promoting effect as well as the ability of the innovative treatment method of FTY720-CDs@GelMA paired with NSCs to increase motor function recovery in a rat spinal cord injury model. Methods: Carbon dots (CDs) and fingolimod (FTY720) were added to a hydrogel created by chemical cross-linking GelMA (FTY720-CDs@GelMA). The basic properties of FTY720-CDs@GelMA hydrogels were investigated using TEM, SEM, XPS, and FTIR. The swelling and degradation rates of FTY720-CDs@GelMA hydrogels were measured, and each group's ability to scavenge reactive oxygen species was investigated. The in vitro biocompatibility of FTY720-CDs@GelMA hydrogels was assessed using neural stem cells. The regeneration of the spinal cord and recovery of motor function in rats were studied following co-treatment of spinal cord injury using FTY720-CDs@GelMA hydrogel in combination with NSCs, utilising rats with spinal cord injuries as a model. Histological and immunofluorescence labelling were used to determine the regeneration of axons and neurons. The recovery of motor function in rats was assessed using the BBB score. Results: The hydrogel boosted neurogenesis and axonal regeneration by eliminating excess ROS and restoring the regenerative environment. The hydrogel efficiently contained brain stem cells and demonstrated strong neuroprotective effects in vivo by lowering endogenous ROS generation and mitigating ROS-mediated oxidative stress. In a follow-up investigation, we discovered that FTY720-CDs@GelMA hydrogel could dramatically boost NSC proliferation while also promoting neuronal regeneration and synaptic formation, hence lowering cavity area. Conclusion: Our findings suggest that the innovative treatment of FTY720-CDs@GelMA paired with NSCs can effectively improve functional recovery in SCI patients, making it a promising therapeutic alternative for SCI. Keywords: spinal cord injury, carbon dots, FTY720, neural stem cells, hydrogel, GelMA, nerve damage repair Direct and rapid mechanical damage to the spinal cord causes spinal cord injury (SCI), which results in permanent motor impairments (weakness or paralysis), sensory deficiencies, and autonomic dysfunction. A cystic cavity is formed as a result of a succession of pathophysiological processes that contribute to extracellular matrix degeneration, such as inflammation, neuronal injury, and death. 1–3 The cavity hinders cellular infiltration and axon regrowth, which eventually becomes a major barrier to nerve regeneration after SCI. 4,5 Following spinal cord injury, the injured site loses a large number of endogenous neural stem cells (NSCs) as well as neurons, which is followed by an exacerbation of the secondary injury cascade, which eventually leads to the formation of a neuroglial scar around the lesion, inhibiting nerve regeneration. 6–8 Changes in the microenvironment, together with CNS neurons' lower regenerative capacity, result in a considerable decline in the self-repairing capacity of spinal cord tissues. In such cases, any treatment that focuses on a single element is unlikely to result in successful brain tissue repair. It has been proven that concurrent therapy of cell transplantation and decrease of glial scarring following spinal cord damage can improve subsequent recovery. 9,10 Previously, biomaterials and their composite scaffold constructions were widely used in animal models to increase the proliferation and differentiation of transplanted stem cells and to minimize scarring at the transplantation site. 11,12 However, because the spinal cord injury region is frequently an irregular sac-cavity structure, typical scaffolds frequently do not suit the shape of the spinal cord injury region well, which is extremely detrimental to subsequent spinal cord injury recovery. Biomaterials and tissue engineering methods -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology